Home›Companies›Healthcare›Science

Science Corp

Develops medical devices for people with vision loss and other serious conditions.

Updated Nov 11, 2026·Latest SEC filing Mar 6, 2026·Suggest an edit

About Science

Science is a private company based in Alameda, California, incorporated in 2021 in Delaware. It has reported $406,979,084 raised in four offerings on Form D since July 2021. Its chief executive is Max Hodak.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 26, 2026Mar 6, 2026$230,049,745of $250.0M target40$5.7MEquity, Offering of Series C, Series C-1 and Series C-2 Preferred Stock (collectively, "Series C"), and the underlying shares of Common Stock issuable upon conversion of Series C.Rule 506(b)Form D ↗
Mar 28, 2025Apr 14, 2025$103,604,355of $110.0M target29$3.5MDebt, Offering of convertible promissory notes ("Notes") and the underlying equity securities issuable upon conversion of Notes.Rule 506(b)Form D ↗
May 23, 2024Jun 7, 2024$25,999,998of $50.0M target5$5.1MEquityRule 506(b)Form D ↗
Jul 6, 2021Jul 21, 2021$47,324,986of $49.5M target14$3.3MEquityRule 506(b)Form D ↗
Total, four offerings$406,979,084

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Science's Form D filed Mar 6, 2026.

AF
Alex Feerst
Executive officer
JM
Jed McCaleb
Director
AM
Alan Mardinly
Executive officer
MH
Max Hodak
Chief Executive Officer and director
Also an executive officer at Neuralink.

Earlier filings also listed Tricia Gugler (executive officer, last listed Apr 2025).

Sources

  1. SECScience Corp filing history